title: [Diagnosis and treatment of psychogenic dizziness in patients with arterial hypertension].
abstract: OBJECTIVE
  To analyze the prevalence, methods of diagnosis and treatment of psychogenic dizziness in patients with arterial hypertension and evaluate the efficacy of treatment with noophen and betahistin.
  
  
  METHODS
  Fifty-eight patients were studied. Patients of the main group received noophen and patients of the comparison group were treated with betahistin. Treatment efficacy was assessed on days 1 and 60 by the scores on VAS, HARS, MFI-20 scales.
  
  
  CONCLUSIONS
  The prevalence of psychogenic dizziness in patients with arterial hypertension was 47%. Noophen in dose 500 mg/day significantly (p<0.001) reduced the severity of dizziness, anxiety, asthenia, and headache compared to baseline and to the efficacy of betahistin as well. The drug showed good tolerability.
authors.affiliation: Research Institute of Therapy and Preventive Medicine, Novosibirsk.
authors.forename: S N
authors.initials: SN
authors.lastname: Duma
authors.affiliation: Research Institute of Therapy and Preventive Medicine, Novosibirsk.
authors.forename: L V
authors.initials: LV
authors.lastname: Shcherbakova
mesh_terms: D000368:Aged; D001007:Anxiety / Q000188:drug therapy / Q000523:psychology; D001247:Asthenia / Q000188:drug therapy / Q000523:psychology; D001621:Betahistine / Q000627:therapeutic use*; D004244:Dizziness / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000523:psychology; D008297:Male; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D005680:gamma-Aminobutyric Acid; C008842:4-amino-3-phenylbutyric acid; D001621:Betahistine